Source: Annual Congress 2006 - Miscellaneous respiratory infections I
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. V. Popovych, K. E. Bogats‘ka (Dnipropetrovs‘k, Ukraine). The etiological agents of community-acquired pneumonia in our hospital. Eur Respir J 2006; 28: Suppl. 50, 4218

Member's Comments

No comment yet.

Related content which might interest you: Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 The peculiarity of etiological agents of community-acquired pneumonia depends on the severity Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 Etiological spectrum of hospitalized community-acquired pneumonia Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Anti-Pseudomonas antibiotic use for hospitalized patients with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Bacteraemia in outpatients with community-acquired pneumonia Source: Eur Respir J 2016; 47: 654-657 Year: 2016 MRSA as a cause of community-acquired pneumonia Source: Eur Respir J 2009; 34: 1013-1014 Year: 2009 The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Are corticosteroids useful in community-acquired pneumonia? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Atypical agents of community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 485s Year: 2003 Usefullness of CPR and PCT in the etiological diagnosis of community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 The approach to antibiotic treatment in community-acquired pneumonia Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia Year: 2008 Risk factors of paediatric community-acquired pneumonia Source: Eur Respir J 2011; 37: 724-725 Year: 2011 Oral antibiotics prior to hospitalisation for community-acquired pneumonia Source: Eur Respir J 2008; 31: 478-479 Year: 2008